Point of Care connectivity drives productivity and quality
Siemens blood gas analysers and data management system installed at Warrington Hospital

Warrington Hospital, part of Warrington and Halton Hospitals NHS Foundation Trust, is one of the first hospitals in the UK to install eight RAPIDLab® 1200 Blood Gas Analysers and a RAPIDComm® v3.0 Blood Gas and Urinalysis Data Management system from Siemens Healthcare Diagnostics.

As diabetes rates soar, consolidating HbA1c testing onto an immunoassay platform can solve throughput problems and reduce costs.

Roche offers free evaluation kit for the Tina-quant® [a] HbA1c Generation 2 assay – an efficient, accurate, cost effective hbA1c testing solution that is easily consolidated onto several Roche platforms.
 

Time and Labour Saving Assay to Identify Paracetamol Overdose

The Roche Acetaminophen (Paracetamol) 10 minutes-to-result assay is an easy to use and effective low-cost method for laboratories to incorporate into their routine testing menu.  The assay is easily incorporated onto a Roche platform, which combined with ready-to-use reagents, ensures time and labour savings.  Additionally, the 2-shot assay has no interference with the Paracetemol Antidode N-Acetylcysteine, making it extremely reliable for consistent patient follow-up.

Cost Effective Antibiotic Honey Screening – A ‘Sweet Investment’

Honey is considered a natural and healthy product. Traditionally considered pure and free from contaminants, this food group has come under intensive scrutiny following recent food scares where antibiotic drug residues were found in imported honey.

NICE draft guidance on cardiac output monitoring device published for consultation

ISSUED: Monday 4 October 2010

Draft guidance from the new NICE medical technologies programme on a cardiac output monitoring device is issued today for consultation. Provisional recommendations are made supporting the use of CardioQ-ODM, when it’s used in patients undergoing surgical procedures who would otherwise require invasive cardiac monitoring. For critically ill patients, however, there wasn’t enough evidence for CardioQ-ODM to be recommended in preference to other cardiac output monitoring devices.